CytoVas forges cardiovascular Dx partnership with Becton

04/29/2013 | MedCityNews.com

CytoVas will work with Becton Dickinson to advance the development of a blood-based test that can be used to identify a person's risk for stroke and cardiovascular disease. The partnership will aid CytoVas in evaluating cardiovascular disease progression and complications tied to experimental and existing cardiovascular drugs.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC